FDA Approved: FOSAPREPITANT DIMEGLUMINE — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved the original application for fosaprepitant dimeglumine from Eugia US LLC, a generic NK1 receptor antagonist for preventing chemotherapy-induced nau…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• fosaprepitant dimeglumine (fosaprepitant dimeglumine)

Snippet

ORIG AP for FOSAPREPITANT DIMEGLUMINE (FOSAPREPITANT DIMEGLUMINE)